William Chase — Intellia Therapeutics Director Compensation (2025)

What they were paid

Intellia Therapeutics Director Compensation Table · the one fiscal year held

In US dollars, as Intellia Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal year	Cash fees	Stock awards	Option awards	Other	Total
FY2025	$72,500	$66,960	$65,740	—	$205,200

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Intellia Therapeutics, Inc. DEF 14A filed April 30, 2026, accession 0001193125-26-197283, and prior-year filings. Open the filing on EDGAR.

The rest of the Intellia Therapeutics board

FY2025 · as the company reported each

Director	Role	FY2025 total
Brian Goff	Independent Director	$196,440
Frank Verwiel	Independent Director	$232,700

The full Intellia Therapeutics compensation record

free company brief

This page is one director within Intellia Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat